COCP – cocrystal pharma, inc. (US:NASDAQ)
Stock Stats
News
Enrollment Completed in Phase 2a Study with Cocrystal Pharma's Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal Influenza [Yahoo! Finance]
Enrollment Completed in Phase 2a Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal Influenza
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs [Yahoo! Finance]
Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Form DEF 14A Cocrystal Pharma, Inc. For: May 07
Form 8-K Cocrystal Pharma, Inc. For: May 01
Form PRE 14A Cocrystal Pharma, Inc. For: Apr 26
Form 10-K/A Cocrystal Pharma, Inc. For: Dec 31
Form 10-K Cocrystal Pharma, Inc. For: Dec 31
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.